These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 21978982

  • 61. Ammonium: the deadly toxin you don't want to miss when using mood stabilizers.
    Kowalski PC, Dowben JS, Keltner NL.
    Perspect Psychiatr Care; 2013 Oct; 49(4):221-5. PubMed ID: 25187442
    [No Abstract] [Full Text] [Related]

  • 62. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Velioğlu SK, Gazioğlu S.
    Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
    [Abstract] [Full Text] [Related]

  • 63. Carnitine supplementation for valproate-related hyperammonemia to maintain therapeutic valproate level.
    Sonik P, Hilty DM, Rossaro L, Bourgeois JA.
    J Clin Psychopharmacol; 2011 Oct; 31(5):680-2. PubMed ID: 21881462
    [No Abstract] [Full Text] [Related]

  • 64. Valproate overdose leading to hyperammonaemic encephalopathy.
    Sharma DS, Gupta S, Sharma P.
    BMJ Case Rep; 2023 Jul 09; 16(7):. PubMed ID: 37423637
    [Abstract] [Full Text] [Related]

  • 65. Valproate-induced encephalopathy in a comorbid elderly woman.
    Gandolfo F, Parodi MN, Corsini GP, Odetti P, Serafini G, Monacelli F.
    Psychogeriatrics; 2017 May 09; 17(3):208-209. PubMed ID: 28093879
    [No Abstract] [Full Text] [Related]

  • 66. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
    Melexopoulou C, Marinaki S, Darema M, Skalioti C, Efthimiou A, Zavos G, Boletis JN.
    Ren Fail; 2014 Jul 09; 36(6):955-6. PubMed ID: 24665854
    [Abstract] [Full Text] [Related]

  • 67. On the toxicity of valproic-acid.
    Moreiras Plaza M, Rodríguez Goyanes G, Cuiña L, Alonso R.
    Clin Nephrol; 1999 Mar 09; 51(3):187-9. PubMed ID: 10099893
    [Abstract] [Full Text] [Related]

  • 68. The real mechanism of VPA-induced hyperammonemia remains unknown.
    Hung CC, Li TM, Wei IH, Huang CC.
    Gen Hosp Psychiatry; 2011 Mar 09; 33(1):84.e3-4. PubMed ID: 21353142
    [Abstract] [Full Text] [Related]

  • 69. [A case of valproate-associated hyperammonemia with chronic hepatitis C].
    Fukushima M, Kotoh K, Enjoji M, Nakamuta M, Nawata H, Aishima S.
    Nihon Shokakibyo Gakkai Zasshi; 2005 Jan 09; 102(1):42-7. PubMed ID: 15682815
    [No Abstract] [Full Text] [Related]

  • 70. [A severe, reversible encephalopathy after prolonged use of valproic acid].
    van Haaren PCF, Bloemkolk D, Rundervoort RS, Gerritse FL.
    Tijdschr Psychiatr; 2023 Jan 09; 65(1):50-53. PubMed ID: 36734691
    [Abstract] [Full Text] [Related]

  • 71. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
    Young L, Coffey BJ.
    J Child Adolesc Psychopharmacol; 2010 Oct 09; 20(5):449-52. PubMed ID: 20973717
    [No Abstract] [Full Text] [Related]

  • 72. Risperidone, a risk factor for valproate-induced encephalopathy?
    Rodrigues-Silva N, Venâncio Â, Bouça J.
    Gen Hosp Psychiatry; 2013 Oct 09; 35(4):452.e5-6. PubMed ID: 23317937
    [Abstract] [Full Text] [Related]

  • 73. Therapeutic drug monitoring of free fraction valproic acid in patients with hypoalbuminaemia.
    Jansen AJ, Hunfeld NG, van Bommel J, Koch BC, van Gelder T.
    Neth J Med; 2012 Sep 09; 70(7):329. PubMed ID: 22961830
    [No Abstract] [Full Text] [Related]

  • 74. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA, Abdella MM.
    Epilepsy Res; 2009 Sep 09; 86(1):32-41. PubMed ID: 19446440
    [Abstract] [Full Text] [Related]

  • 75. Valproate-induced hyperammonemic encephalopathy.
    Yehya N, Saldarini CT, Koski ME, Davanzo P.
    J Am Acad Child Adolesc Psychiatry; 2004 Aug 09; 43(8):926-7. PubMed ID: 15266186
    [No Abstract] [Full Text] [Related]

  • 76. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT, Burcet J, Ramió L, Ustrell X, Silva Y, Molins A.
    Neurologia; 2003 Aug 09; 18(6):347-50. PubMed ID: 12838456
    [Abstract] [Full Text] [Related]

  • 77. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
    Fassi G, Igoa A, Liste OA.
    Vertex; 2008 Aug 09; 19(82):371-7. PubMed ID: 19424520
    [Abstract] [Full Text] [Related]

  • 78. Pancreatic pseudocyst caused by valproic acid: case report and review of the literature.
    Queizán A, Hernández F, Rivas S.
    Eur J Pediatr Surg; 2003 Feb 09; 13(1):60-2. PubMed ID: 12664419
    [Abstract] [Full Text] [Related]

  • 79. Cerebral and cerebellar pseudoatrophy associated with valproic acid. Report of three pediatric cases.
    Ordoño-Saiz MV, Púa-Torrejón RC, Justel-Rodríguez M, Arias-Vivas E, Heppe-Montero M, González-Alguacil E, Duat-Rodríguez A, Ruiz-Falcó-Rojas ML, García-Peñas JJ, Gutiérrez-Delicado E, Soto-Insuga V.
    Rev Neurol; 2023 Oct 16; 77(8):197-201. PubMed ID: 37807884
    [Abstract] [Full Text] [Related]

  • 80. Fanconi syndrome caused by valproic acid.
    Endo A, Fujita Y, Fuchigami T, Takahashi S, Mugishima H.
    Pediatr Neurol; 2010 Apr 16; 42(4):287-90. PubMed ID: 20304335
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.